Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
10.80
-0.36 (-3.23%)
Jun 5, 2025, 10:24 AM - Market open

Bicara Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
462.07489.71230.444.16
Cash & Short-Term Investments
462.07489.71230.444.16
Cash Growth
100.51%112.51%5442.09%-
Receivables
--0.10.07
Prepaid Expenses
8.6912.820.530.76
Total Current Assets
470.75502.53231.074.98
Property, Plant & Equipment
0.690.850.820.64
Other Long-Term Assets
6.646.621.990.94
Total Assets
478.08510233.986.7
Accounts Payable
2.744.513.195.14
Accrued Expenses
15.7912.8811.6118.76
Current Portion of Leases
0.590.610.29-
Total Current Liabilities
19.1217.9915.0923.9
Long-Term Leases
-0.130.37-
Other Long-Term Liabilities
--0.020.09
Total Liabilities
19.1218.1215.4723.98
Common Stock
0.010.0100
Additional Paid-In Capital
716.81712.884.252.23
Retained Earnings
-257.86-221.02-153.02-101.04
Total Common Equity
458.96491.88-148.77-98.8
Shareholders' Equity
458.96491.88218.51-17.28
Total Liabilities & Equity
478.08510233.986.7
Total Debt
0.590.740.66-
Net Cash (Debt)
461.47488.97229.784.16
Net Cash Growth
100.83%112.80%5426.29%-
Net Cash Per Share
15.2529.10396.109.69
Filing Date Shares Outstanding
54.5454.5234.260.43
Total Common Shares Outstanding
54.5354.440.640.43
Working Capital
451.63484.54215.99-18.91
Book Value Per Share
8.429.04-232.15-230.26
Tangible Book Value
458.96491.88-148.77-98.8
Tangible Book Value Per Share
8.429.04-232.15-230.26
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q